Osaic Holdings’s Ginkgo Bioworks DNA Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $42.9K | Sell |
4,370
-1,168
| -21% | -$11.5K | ﹤0.01% | 4811 |
|
2025
Q1 | $31.5K | Buy |
5,538
+990
| +22% | +$5.64K | ﹤0.01% | 5012 |
|
2024
Q4 | $44.6K | Sell |
4,548
-4,531
| -50% | -$44.4K | ﹤0.01% | 4769 |
|
2024
Q3 | $74K | Sell |
9,079
-445
| -5% | -$3.63K | ﹤0.01% | 4429 |
|
2024
Q2 | $126K | Sell |
9,524
-6,175
| -39% | -$82K | ﹤0.01% | 3936 |
|
2024
Q1 | $728K | Buy |
15,699
+330
| +2% | +$15.3K | ﹤0.01% | 2625 |
|
2023
Q4 | $1.04M | Buy |
15,369
+5,918
| +63% | +$400K | ﹤0.01% | 2470 |
|
2023
Q3 | $684K | Buy |
9,451
+1,978
| +26% | +$143K | ﹤0.01% | 2985 |
|
2023
Q2 | $557K | Buy |
7,473
+316
| +4% | +$23.5K | ﹤0.01% | 3058 |
|
2023
Q1 | $381K | Buy |
7,157
+2,702
| +61% | +$144K | ﹤0.01% | 3326 |
|
2022
Q4 | $300K | Buy |
4,455
+2,226
| +100% | +$150K | ﹤0.01% | 3516 |
|
2022
Q3 | $278K | Buy |
2,229
+200
| +10% | +$24.9K | ﹤0.01% | 3446 |
|
2022
Q2 | $194K | Buy |
2,029
+696
| +52% | +$66.5K | ﹤0.01% | 3824 |
|
2022
Q1 | $215K | Buy |
1,333
+65
| +5% | +$10.5K | ﹤0.01% | 3968 |
|
2021
Q4 | $423K | Buy |
1,268
+165
| +15% | +$55K | ﹤0.01% | 3224 |
|
2021
Q3 | $510K | Buy |
+1,103
| New | +$510K | ﹤0.01% | 3009 |
|